vs 6,526 other HR bills in the 114th — cohort avg 56d
Summary
Lymphedema Treatment Act This bill amends title XVIII (Medicare) of the Social Security Act to cover certain lymphedema compression treatment items as durable medical equipment under Medicare. (Lymphedema is a condition of localized fluid retention and tissue swelling that is caused when the lymphatic system is damaged or blocked.)
Lobbying filings that explicitly cite this bill (47)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Client expense: $1,640,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Client expense: $1,620,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Client expense: $1,630,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; S.1488/H.R.2624, Part D Beneficiary Appeals Fairness Act, issues related to out-of-pocket costs for prescription drugs.
Client expense: $38,415 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
HR 775/S 539 - Medicare Access to Rehabilitation Services Act: Advocate for removal of cap on occupational therapy services and support passage.
HR 1516 - Ensuring Access and Quality Complex Rehabilitation Technology Act of 2015: Advocate for inclusion of occupational therapy professionals as providers of complex rehabilitation technology.
HR 1608 - Lymphedema Treatment Act: Support passage and educate about role of occupational therapy services.
HR 729 - Medicare Demonstration of Coverage for Low Vision Devices Act of 2015: Support passage and education about role of occupational therapy services.
HR 6 - 21st Century Cures Act: Advocated to improve research under the National Institutes of Health (NIH)and inclusion of the Occupational Therapy Mental Health Act (HR 1761)language and inclusion of occupational therapy in the SAMHSA strategic plan.
S. 313 - Prevent Interruptions in Physical Therapy Act: Advocated for inclusion of occupational therapy, specifically policies allowing occupational therapists to perform certain home health assessments.
S. 2364/HR6404 - The Medicare Home Health Flexibility Act: support passage to allow occupational therapy as an initiating service in Medicare's home health setting. Seeking introduction of a companion bill in the House of Reps.
H.R. 2948 - Medicare Telehealth Parity Act of 2015: Support passage especially as it relates to inclusion of occupational therapy services.
S. 2484/HR 4442 - CONNECT for Health Act: Support occupational therapy provisions.
No bill: Advocate for inclusion of occupational therapy services in legislation addressing the needs of those with chronic conditions.
HR 5926/S 3040, Fiscal 2017 Labor-HHS-Education Appropriations - Advocated for funding for Agency for Health Research & Quality (AHRQ); Center for Medicare and Medicaid Innovation (CMMI); Center for Medicare and Medicaid Services (CMS); Substance Abuse and Mental Health Services Administration (SAMHSA); Administration for Children and Families (ACF); Administration for Community Living (ACL); education; Increase 302B levels, Title VII workforce programs and NIOSH.
HR 3298, Medicare Post-Acute Care Value Based Purchasing Act: Advocated for more focus on function, quality, and long-term outcomes.
Client expense: $190,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
H.R. 582/S. 307 ConTACT Act
H.R. 1383 Medicare Adult Day Services Act
H.R. 263 Adult Day Care Enhancement Act
H.R. 1707 Access to Frontline Healthcare Act
H.R. 395/S. 536 Indian Health Service Health Professionals Tax Fairness Act
H.R. 2 SGR Repeal
Physician self-referra/Stark Law
American Cures Act
H.R. 1608/S. 2373 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
H.R. 1190/S. 141 IPAB repeal
H.R. 1741 Truth In Healthcare Marketing Act
Medicaid Expansion
HR. 2342/S. 1426 Physical Therapist Workforce & Patient Access Act
Physician owned distributerships
H.R. 921/S. 689 Sports Medicine Licensure Clarity Act
S. 2364 Medicare Home Health Flexibility Act
MACRA/MIPS
APMS
IMPACT/PAC reform
Network adequacy
Insurance Benefit parameters
H.R. 4641 To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes.
S. 524/H.R. 953 Comprehensive Addiction & Recovery Act of 2015
H.R. 5088 PIMA
H.R. 5045 Preserving Access to Modern Prosthetic Limbs Act of 2016
H.R. 4266 Nurse & Health Care Worker Protection Act
H.R. 1516 Ensuring Access to Quality CRT
H.R. 1530 Medicare O&P Improvement Act
H.R. 1420 National TBI Research & Treatment Improvement Act
H.R. 2948 Medicare Telehealth Parity Act of 2015
S. 800/H.R. 1631 Enhancing the Stature and Visibility of Medicare Research at NIH Act
Client expense: $258,406 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Chronic care management of Lymphedema disease, including S. 2372 and HR 1608, the Lymphedema Treatment Act. Monitor H.R. 34, the 21st Century Cures Act.
Client expense: Not reported · Firm income: $18,000
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Client expense: $1,200,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
H.R. 582/S. 307 ConTACT Act
H.R. 1383 Medicare Adult Day Services Act
H.R. 263 Adult Day Care Enhancement Act
H.R. 1707 Access to Frontline Healthcare Act
H.R. 395/S. 536 Indian Health Service Health Professionals Tax Fairness Act
H.R. 2 SGR Repeal
Physician self-referra/Stark Law
American Cures Act
H.R. 1608/S. 2373 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
H.R. 1190/S. 141 IPAB repeal
H.R. 1741 Truth In Healthcare Marketing Act
Medicaid Expansion
HR. 2342/S. 1426 Physical Therapist Workforce & Patient Access Act
Physician owned distributerships
H.R. 921/S. 689 Sports Medicine Licensure Clarity Act
S. 2364 Medicare Home Health Flexibility Act
MACRA/MIPS
APMS
IMPACT/PAC reform
Network adequacy
Insurance Benefit parameters
H.R. 4641 To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes.
S. 524/H.R. 953 Comprehensive Addiction & Recovery Act of 2015
H.R. 5088 PIMA
H.R. 5045 Preserving Access to Modern Prosthetic Limbs Act of 2016
H.R. 4266 Nurse & Health Care Worker Protection Act
H.R. 1516 Ensuring Access to Quality CRT
H.R. 1530 Medicare O&P Improvement Act
H.R. 1420 National TBI Research & Treatment Improvement Act
H.R. 2948 Medicare Telehealth Parity Act of 2015
S. 800/H.R. 1631 Enhancing the Stature and Visibility of Medicare Research at NIH Act
Client expense: $258,406 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
HR 775/S 539 - Medicare Access to Rehabilitation Services Act: Advocate for removal of cap on occupational therapy services and support passage.
HR 1516 - Ensuring Access and Quality Complex Rehabilitation Technology Act of 2015: Advocate for inclusion of occupational therapy professionals as providers of complex rehabilitation technology.
HR 1608 - Lymphedema Treatment Act: Support passage and educate about role of occupational therapy services.
HR 729 - Medicare Demonstration of Coverage for Low Vision Devices Act of 2015: Support passage and education about role of occupational therapy services.
HR 6 - 21st Century Cures Act: Advocated to improve research under the National Institutes of Health (NIH).
S. 313 - Prevent Interruptions in Physical Therapy Act: Advocated for inclusion of occupational therapy, specifically policies allowing occupational therapists to perform certain home health assessments.
S. 2364 - The Medicare Home Health Flexibility Act: support passage to allow occupational therapy as an initiating service in Medicare's home health setting. Seeking introduction of a companion bill in the House of Reps.
H.R. 2948 - Medicare Telehealth Parity Act of 2015: Support passage especially as it relates to inclusion of occupational therapy services.
S. 2484/HR 4442 - CONNECT for Health Act: Support occupational therapy provisions.
No bill: Advocate for inclusion of occupational therapy services in legislation addressing the needs of those with chronic conditions.
HR 5926/S 3040, Fiscal 2017 Labor-HHS-Education Appropriations - Advocated for funding for Agency for Health Research & Quality (AHRQ); Center for Medicare and Medicaid Innovation (CMMI); Center for Medicare and Medicaid Services (CMS); Substance Abuse and Mental Health Services Administration (SAMHSA); Administration for Children and Families (ACF); Administration for Community Living (ACL); education; Increase 302B levels, Title VII workforce programs and NIOSH.
HR 3298, Medicare Post-Acute Care Value Based Purchasing Act: Advocated for more focus on function, quality, and long-term outcomes.
Cited source text, amounts, lobbyists, and targets
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; S.1488/H.R.2624, Part D Beneficiary Appeals Fairness Act, issues related to out-of-pocket costs for prescription drugs.
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opiod prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments.
Client expense: $1,250,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
HR 775/S 539 - Medicare Access to Rehabilitation Services Act: Advocate for removal of cap on occupational therapy services and support passage.
HR 1516 - Ensuring Access and Quality Complex Rehabilitation Technology Act of 2015: Advocate for inclusion of occupational therapy professionals as providers of complex rehabilitation technology.
HR 1608 - Lymphedema Treatment Act: Support passage and educate about role of occupational therapy services.
HR 729 - Medicare Demonstration of Coverage for Low Vision Devices Act of 2015: Support passage and education about role of occupational therapy services.
HR 6 - 21st Century Cures Act: Advocated to improve research under the National Institutes of Health (NIH).
S. 313 - Prevent Interruptions in Physical Therapy Act: Advocated for inclusion of occupational therapy, specifically policies allowing occupational therapists to perform certain home health assessments.
S. 2364 - The Medicare Home Health Flexibility Act: support passage to allow occupational therapy as an initiating service in Medicare's home health setting. Seeking introduction of a companion bill in the House of Reps.
H.R. 2948 - Medicare Telehealth Parity Act of 2015: Support passage especially as it relates to inclusion of occupational therapy services.
S. 2484/HR 4442 - CONNECT for Health Act: Support occupational therapy provisions.
No bill: Advocate for inclusion of occupational therapy services in legislation addressing the needs of those with chronic conditions.
Client expense: $170,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 4499, Promoting Responsible Opioid Prescribing (PROP) Act of 2016, all provisions
S. 2758, Promoting Responsible Opioid Prescribing (PROP) Act of 2016, all provisions
H.R. 976, Patient Access to Higher Quality Health Care Act of 2015, all provisions
H.R. 5273, Helping Hospitals Improve Patient Care Act of 2016, all provisions
H.R. 2977, Furthering Access to Stroke Telemedicine (FAST) Act, all provisions
H.R. 21102, Medicare Diabetes Prevention Act of 2015, all provisions
S. 1131, Medicare Diabetes Prevention Act of 2015, all provisions
H.R. 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, provisions relating to delivery and payment reform
S. 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, provisions relating to delivery and payment reform
H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015, all provisions
H.R. 4442, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, all provisions
S. 2484, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, all provisions
S. 1913, Stopping Medication Abuse and Protecting Seniors Act of 2015, all provisions
H.R. 1608, Lymphedema Treatment Act, all provisions
S. 2373, Lymphedema Treatment Act, all provisions
S. 2943, National Defense Authorization Act for Fiscal Year 2017, provisions relating to Telemedicine and licensure
Medicare program: Diabetes prevention
Medicare program: IPAB Repeal
Medicare program: Medicare Access and CHIP Reauthorization Act (MACRA) Implementation
Medicare program: MACRA physician compliance flexibility
Medicare program: Quality Payment Program (QPP)
Medicare program: Protecting Access to Medicare Act (PAMA) implementation
Medicare program: Merit-Based Incentive Payment System (MIPS)
Medicare program: Value-Based Modifier (VBM)
Medicare program: Advancing Care Information (ACI) score
Medicare program: Clinical Practice Improvement Activities (CPIAs)
Medicare program: Resource Use
Medicare program: Alternative Payment Models (APMs)
Medicare program: Physician Quality Reporting System (PQRS)
Medicare program: Graduate Medical Education (GME)
Medicare program: Prescription Drug Diversion/Opioid abuse
Medicare program: Physician data
Medicare program: Adding unique device identifier to billing form
Medicare program: Physician-owned hospital moratorium
Medicare program: Physician Office-based Labs (POLS)
Medicare program: EHR/Meaningful Use
Medicare program: Sunshine Act
Medicare program: Part B Drug Demonstration/Reimbursement
Medicare program: In-Office Ancillary Services Exception
Medicare program: Provider networks adequacy and balance billing
Medicare program: AHIP-CMS Core Measure activity
Medicare program: Comprehensive joint replacement
Medicare program: Chronic care
Medicare program: Home health prior authorization
Medicare program: Telehealth
Medicare program: Clinical Trials - insurance coverage improvements
Medicare program: Coverage policy
Medicare program: Program Integrity/Provider Enrollment
Medicare and Medicaid programs: EHR interoperability/digital health
Medicaid program: State Medicaid cuts
Cited source text, amounts, lobbyists, and targets
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; S.1488/H.R.2624, Part D Beneficiary Appeals Fairness Act, issues related to out-of-pocket costs for prescription drugs.
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
H.R. 582/S. 307 ConTACT Act
H.R. 1383 Medicare Adult Day Services Act
H.R. 263 Adult Day Care Enhancement Act
H.R. 1707 Access to Frontline Healthcare Act
H.R. 395/S. 536 Indian Health Service Health Professionals Tax Fairness Act
H.R. 2 SGR Repeal
Physician self-referral
American Cures Act
H.R. 1608/S. 2373 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
H.R. 1190/S. 141 IPAB repeal
H.R. 1741 Truth In Healthcare Marketing Act
Medicaid Expansion
HR. 2342/S. 1426 Physical Therapist Workforce & Patient Access Act
Physician owned distributerships
H.R. 921/S. 689 Sports Medicine Licensure Clarity Act
S. 2364 Medicare Home Health Flexibility Act
MACRA/MIPS
APMS
IMPACT/PAC reform
Network adequacy
Insurance Benefit parameters
H.R. 4641 To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes.
S. 524/H.R. 953 Comprehensive Addiction & Recovery Act of 2015
H.R. 5088 PIMA
H.R. 5045 Preserving Access to Modern Prosthetic Limbs Act of 2016
H.R. 4266 Nurse & Health Care Worker Protection Act
H.R. 1516 Ensuring Access to Quality CRT
H.R. 1530 Medicare O&P Improvement Act
H.R. 1420 National TBI Research & Treatment Improvement Act
H.R. 2948 Medicare Telehealth Parity Act of 2015
S. 800/H.R. 1631 Enhancing the Stature and Visibility of Medicare Research at NIH Act
Client expense: $253,752 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Client expense: $760,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
HR 775/S 539 - Medicare Access to Rehabilitation Services Act: Advocate for removal of cap on occupational therapy services and support passage.
HR 1516 - Ensuring Access and Quality Complex Rehabilitation Technology Act of 2015: Advocate for inclusion of occupational therapy professionals as providers of complex rehabilitation technology.
HR 1608 - Lymphedema Treatment Act: Support passage and educate about role of occupational therapy services.
HR 729 - Medicare Demonstration of Coverage for Low Vision Devices Act of 2015: Support passage and education about role of occupational therapy services.
HR 1458 - Bundling and Coordinating Post-Acute Care Act of 2015 (BACPAC Act of 2015): Provide information on occupational therapy's role in bundled payment.
HR 6 - 21st Century Cures Act: Advocated to improve research under the National Institutes of Health (NIH).
S. 313 - Prevent Interruptions in Physical Therapy Act: Advocated for inclusion of occupational therapy, specifically policies allowing occupational therapists to perform certain home health assessments.
S. 2364 - The Medicare Home Health Flexibility Act: support passage to allow occupational therapy as an initiating service in Medicare's home health setting. Seeking introduction of a companion bill in the House of Reps.
H.R. 2948 - Medicare Telehealth Parity Act of 2015: Support passage especially as it relates to inclusion of occupational therapy services.
S. 2484/HR 4442 - CONNECT for Health Act: Support occupational therapy provisions.
No bill: Advocate for inclusion of occupational therapy services in legislation addressing the needs of those with chronic conditions.
Client expense: $110,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Client expense: $760,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care; S.1488/H.R.2624, Part D Beneficiary Appeals Fairness Act, issues related to out-of-pocket costs for prescription drugs.
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
H.R. 582/S. 307 ConTACT Act
H.R. 1383 Medicare Adult Day Services Act
H.R. 263 Adult Day Care Enhancement Act
H.R. 1707 Access to Frontline Healthcare Act
H.R. 395/S. 536 Indian Health Service Health Professionals Tax Fairness Act
H.R. 2 SGR Repeal
Physician self-referral
American Cures Act
H.R. 1608 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
H.R. 1190/S. 141 IPAB repeal
H.R. 1741 Truth In Healthcare Marketing Act
Medicaid Expansion
Client expense: $302,185 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Client expense: $1,960,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Client expense: $1,960,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
HR 775/S 539 - Medicare Access to Rehabilitation Services Act: Advocate for removal of cap on occupational therapy services and support passage.
HR 1516 - Ensuring Access and Quality Complex Rehabilitation Technology Act of 2015: Advocate for inclusion of occupational therapy professionals as providers of complex rehabilitation technology.
HR 1608 - Lymphedema Treatment Act: Support passage and educate about role of occupational therapy services.
HR 729 - Medicare Demonstration of Coverage for Low Vision Devices Act of 2015: Support passage and education about role of occupational therapy services.
HR 1458 - Bundling and Coordinating Post-Acute Care Act of 2015 (BACPAC Act of 2015): Provide information on occupational therapy's role in bundled payment.
HR 6 - 21st Century Cures Act: Advocated to improve research under the National Institutes of Health (NIH).
S.984 - Steve Gleason Act of 2015: Advocated for Passage
S. 313 - Prevent Interruptions in Physical Therapy Act: Advocated for inclusion of occupational therapy, specifically policies allowing occupational therapists to perform certain home health assessments.
S. 2364 - The Medicare Home Health Flexibility Act: support passage to allow occupational therapy as an initiating service in Medicare's home health setting. Seeking introduction of a companion bill in the House of Reps.
H.R. 2948 - Medicare Telehealth Parity Act of 2015: Support passage especially as it relates to inclusion of occupational therapy services.
Client expense: $150,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2722, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.1170/H.R.2191, Breast Cancer Research Stamp Reauthorization Act, advocate for the reauthorization of the breast cancer research stamp; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; S.1926/H.R.3339, Protecting Access to Lifesaving Screenings Act, amends Title XVIII of the Social Security Act to protect coverage for screening mammography; H.R.2846, Planning Actively for Cancer Treatments Act, support coverage of cancer care planning and coordination services; S.91/H.R.4112, Mobile Mammography Promotion Act, issues related to excluding mobile mammography vehicles from the motor fuel excise tax; H.R.3119, Palliative Care and Hospice Education and Training Act, support federal funding for research, training, education and awareness into palliative care.
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act; an issues before the CDC, including opioid prescription guidelines.
Client expense: $1,190,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
HR 775/S 539 - Medicare Access to Rehabilitation Services Act: Advocate for removal of cap on occupational therapy services and support passage.
HR 1516 - Ensuring Access and Quality Complex Rehabilitation Technology Act of 2015: Advocate for inclusion of occupational therapy professionals as providers of complex rehabilitation technology.
HR 1608 - Lymphedema Treatment Act: Support passage and educate about role of occupational therapy services.
HR 729 - Medicare Demonstration of Coverage for Low Vision Devices Act of 2015: Support passage and education about role of occupational therapy services.
HR 2 - Medicare Access and CHIP Reauthorization Act: Advocate to include full repeal of the cap on Medicare Part B Outpatient therapy, including occupational therapy. Support for SGR provision.
HR 1458 - Bundling and Coordinating Post-Acute Care Act of 2015 (BACPAC Act of 2015): Provide information on occupational therapy's role in bundled payment.
HR 6 - 21st Century Cures Act: Advocated to improve research under the National Institutes of Health (NIH).
S.984 - Steve Gleason Act of 2015: Advocated for Passage
S. 313 - Prevent Interruptions in Physical Therapy Act: Advocated for inclusion of occupational therapy, specifically policies allowing occupational therapists to perform certain home health assessments.
No bill: seek introduction of the Home Health Flexibility Act, to allow occupational therapy as an initiating service in Medicare's home health setting.
Client expense: $130,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1566/H.R.2739, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.1170/H.R.2191, Breast Cancer Research Stamp Reauthorization Act, advocate for the reauthorization of the breast cancer research stamp; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses; H.R.6, 21st Century Cures Act, issues related to cancer prevention and research funding; S.620/H.R.1189, Preserving Employee Wellness Programs Act, issues related to the Genetic Information Act of 2008 and workplace wellness programs; S.1926/H.R.3339, Protecting Access to Lifesaving Screenings Act, amends Title XVIII of the Social Security Act to protect coverage for screening mammography.
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
H.R. 582/S. 307 ConTACT Act
H.R. 1383 Medicare Adult Day Services Act
H.R. 263 Adult Day Care Enhancement Act
H.R. 1707 Access to Frontline Healthcare Act
H.R. 395/S. 536 Indian Health Service Health Professionals Tax Fairness Act
H.R. 2 SGR Repeal
Physician self-referral
American Cures Act
H.R. 1608 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
H.R. 1190/S. 141 IPAB repeal
H.R. 1741 Truth In Healthcare Marketing Act
Medicaid Expansion
HR. 2342/S. 1426 Physical Therapist Workforce & Patient Access Act
Client expense: $243,884 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
H.R. 582/S. 307 ConTACT Act
H.R. 1383 Medicare Adult Day Services Act
H.R. 263 Adult Day Care Enhancement Act
H.R. 1707 Access to Frontline Healthcare Act
H.R. 395/S. 536 Indian Health Service Health Professionals Tax Fairness Act
H.R. 2 SGR Repeal
Physician self-referral
American Cures Act
H.R. 1608 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
H.R. 1190/S. 141 IPAB repeal
Client expense: $292,701 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
H.R. 582/S. 307 ConTACT Act
H.R. 1383 Medicare Adult Day Services Act
H.R. 263 Adult Day Care Enhancement Act
H.R. 1707 Access to Frontline Healthcare Act
H.R. 395/S. 536 Indian Health Service Health Professionals Tax Fairness Act
H.R. 2 SGR Repeal
Physician self-referral
American Cures Act
H.R. 1608 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
H.R. 1190/S. 141 IPAB repeal
H.R. 1741 Truth In Healthcare Marketing Act
Medicaid Expansion
Client expense: $302,185 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
H.R. 582/S. 307 ConTACT Act
H.R. 1383 Medicare Adult Day Services Act
H.R. 263 Adult Day Care Enhancement Act
H.R. 1707 Access to Frontline Healthcare Act
H.R. 395/S. 536 Indian Health Service Health Professionals Tax Fairness Act
H.R. 2 SGR Repeal
Physician self-referral
American Cures Act
H.R. 1608 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
H.R. 1190/S. 141 IPAB repeal
Client expense: $302,185 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including follow-on legislation to H.R.1666 & S.2800, the Patient Centered Quality Care for Life Act, and, H.R.1339 (IH) & S.641, the Palliative Care and Hospice Education and Training Act (113th Congress), H.R.716 & S.370, the Breast Density & Mammography Reporting Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act.
Client expense: $1,310,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
HR 775/S 539 - Medicare Access to Rehabilitation Services Act: Advocate for removal of cap on occupational therapy services and support passage.
HR 1516 - Ensuring Access and Quality Complex Rehabilitation Technology Act of 2015: Advocate for inclusion of occupational therapy professionals as providers of complex rehabilitation technology.
HR 1608 - Lymphedema Treatment Act: Support passage and educate about role of occupational therapy services.
HR 729 - Medicare Demonstration of Coverage for Low Vision Devices Act of 2015: Support passage and education about role of occupational therapy services.
HR 2 - Medicare Access and CHIP Reauthorization Act: Advocate to include full repeal of the cap on Medicare Part B Outpatient therapy, including occupational therapy. Support for SGR provision.
HR 1458 - Bundling and Coordinating Post-Acute Care Act of 2015 (BACPAC Act of 2015): Provide information on occupational therapy's role in bundled payment.
HR 6 - 21st Century Cures Act: Advocated to improve research under the National Institutes of Health (NIH).
S.984 - Steve Gleason Act of 2015: Advocated for Passage
S. 313 - Prevent Interruptions in Physical Therapy Act: Advocated for inclusion of occupational therapy.
Client expense: $200,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
H.R. 582/S. 307 ConTACT Act
H.R. 1383 Medicare Adult Day Services Act
H.R. 263 Adult Day Care Enhancement Act
H.R. 1707 Access to Frontline Healthcare Act
H.R. 395/S. 536 Indian Health Service Health Professionals Tax Fairness Act
H.R. 2 SGR Repeal
Physician self-referral
American Cures Act
H.R. 1608 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
H.R. 1190/S. 141 IPAB repeal
H.R. 1741 Truth In Healthcare Marketing Act
Medicaid Expansion
Client expense: Not reported · Firm income: $302,185
Cited source text, amounts, lobbyists, and targets
Pub. Law No. 111-148, Patient Protection and Affordable Care Act, matters related to the implementation of breast health education, research and clinical trials; S.1695/H.R.3020, Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, issues related to cancer prevention and research funding; S.1558/H.R.2685, Department of Defense Appropriations Act, issues related to cancer prevention and research funding; S.1566/H.R.2739, Cancer Drug Coverage Parity Act, advocate to require insurance companies cover iv-administered and orally-administered anti-cancer drugs at the same cost to patients; H.R.1600, Patients' Access to Treatment Act, support amending the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure and prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier; H.R.1608, Lymphedema Treatment Act, support Medicare coverage of certain lymphedema compression treatment items as durable medical equipment; S.1170/H.R.2191, Breast Cancer Research Stamp Reauthorization Act, advocate for the reauthorization of the breast cancer research stamp; H.R.2722, Breast Cancer Awareness Commemorative Coin Act, support the creation of a breast cancer awareness coin to increase the funding available for breast cancer research; S.370/H.R.716, Breast Density and Mammography Reporting Act, issues related to the information provided to women and doctors on breast density and the potential impact it has on the detection of breast cancer and require the FDA to utilize up to date medical information and direct HHS to focus research on the best screening methods for breast tissue; H.R.1925, Dr. Balazs "Ernie" Bodai Congressional Gold Medal, support the presentation of a congressional gold medal to Dr. Balaz "Ernie" Bodai in recognition of his many outstanding contributions to the nation, including a tireless commitment to breast cancer research; S.1192/H.R.2540, Breast Cancer Patient Education Act, efforts to support creating an educational campaign to inform breast cancer patients anticipating surgery about the availability and coverage of breast reconstruction and prostheses.
Cited source text, amounts, lobbyists, and targets
HR 1608, the Lymphedema Treatment Act, requesting that physician prescribed lymphedema compression supplies would be covered under the Medicare program.
HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program.
[General feedback/No bill introduced] - Urging the Senate Committee on Finance to include establishment of a Medicare cancer care planning service among the reforms it recommends to improve chronic care.
[Comment letter to HHS] - Requesting Medicare reimbursement of advance care planning (ACP) services in CY 2016.
Client expense: $60,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
H.R. 582/S. 307 ConTACT Act
H.R. 1383 Medicare Adult Day Services Act
H.R. 263 Adult Day Care Enhancement Act
H.R. 1707 Access to Frontline Healthcare Act
H.R. 395/S. 536 Indian Health Service Health Professionals Tax Fairness Act
H.R. 2 SGR Repeal
Physician self-referral
American Cures Act
H.R. 1608 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
H.R. 1190/S. 141 IPAB repeal
Client expense: Not reported · Firm income: $38,036
Cited source text, amounts, lobbyists, and targets
HR 775/S 539 - Medicare Access to Rehabilitation Services Act: Advocate for removal of cap on occupational therapy services and support passage.
HR 1516 - Ensuring Access and Quality Complex Rehabilitation Technology Act of 2015: Advocate for inclusion of occupational therapy professionals as providers of complex rehabilitation technology.
HR 1608 - Lymphedema Treatment Act: Support passage and educate about role of occupational therapy services.
HR 729 - Medicare Demonstration of Coverage for Low Vision Devices Act of 2015: Support passage and education about role of occupational therapy services.
HR 2 - Medicare Access and CHIP Reauthorization Act: Advocate to include full repeal of the cap on Medicare Part B Outpatient therapy, including occupational therapy. Support for SGR provision.
HR 1458 - Bundling and Coordinating Post-Acute Care Act of 2015 (BACPAC Act of 2015): Provide information on occupational therapy's role in bundled payment.
Client expense: $200,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA), White House Office
Client expense: $100,208 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Client expense: $80,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office